» Articles » PMID: 27144617

Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV

Overview
Specialty Gastroenterology
Date 2016 May 5
PMID 27144617
Citations 709
Authors
Affiliations
Soon will be listed here.
Abstract

Functional gastrointestinal disorders (FGIDs), the most common diagnoses in gastroenterology are recognized by morphological and physiological abnormalities that often occur in combination including motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota and altered central nervous system processing. Research on these gut-brain interaction disorders is based on using specific diagnostic criteria. The Rome Foundation has played a pivotal role in creating diagnostic criteria thus operationalizing the dissemination of new knowledge in the field of FGIDs. Rome IV is a compendium of the knowledge accumulated since Rome III was published 10 years ago. It improves upon Rome III by: 1) updating the basic and clinical literature, 2) offering new information on gut microenvironment, gut-brain interactions, pharmacogenomics, biopsychosocial, gender and cross cultural understandings of FGIDs, 3) reduces the use of imprecise and occassionally stigmatizing terms when possible, 4) uses updated diagnostic algorithms, 5) incorporates information on the patient illness experience, and physiological subgroups or biomarkers that might lead to more targeted treatment. This introductory article sets the stage for the remaining 17 articles that follow and offers an historical overview of the FGIDs field, differentiates FGIDs from motility and structural disorders, discusses the changes from Rome III, reviews the Rome committee process, provides a biopsychosocial pathophysiological conceptualization of FGIDs, and offers an approach to patient care.

Citing Articles

Characterization of post-inflammatory irritable bowel syndrome animal model following acute colitis recovery.

Jeong E, Jung H, Choi E, Yun K, Lee A, Kim Y Sci Rep. 2025; 15(1):8512.

PMID: 40075091 PMC: 11904205. DOI: 10.1038/s41598-025-88981-7.


Sex-dependent alterations of colonic epithelial permeability: relevance to irritable bowel syndrome.

Larauche M, Mahurkar-Joshi S, Biraud M, Ju T, Mayer E, Chang L Front Physiol. 2025; 16:1509935.

PMID: 40061455 PMC: 11885305. DOI: 10.3389/fphys.2025.1509935.


The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease.

Li P, Tang Y, Liu L, Yang L, Yang L, Sun Z BMC Gastroenterol. 2025; 25(1):136.

PMID: 40045215 PMC: 11883918. DOI: 10.1186/s12876-025-03726-0.


Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases.

Chen S, Shen C, Zeng X, Sun L, Luo F, Wan R Front Microbiol. 2025; 16:1515364.

PMID: 39959156 PMC: 11826063. DOI: 10.3389/fmicb.2025.1515364.


Histology of the Upper Gastrointestinal Tract, Morphometry and Lymphocyte Subpopulations of the Duodenal Mucosa: Insights from Healthy Individuals.

Martin-Cardona A, Carrasco A, Ferrer C, Gonzalez-Minguez C, Luizaga-Velasco L, Tarroch X Int J Mol Sci. 2025; 26(3).

PMID: 39941117 PMC: 11818500. DOI: 10.3390/ijms26031349.